medigraphic.com
Instituto Nacional de Salud Pública

2022, Number 3

<< Back Next >>

salud publica mex 2022; 64 (3)

Mortalidad por Covid-19 en niños y adolescentes en México

Stern D, Arias-de la Garza E, García-Romero MT, Lajous M

Language: English
References: 13
Page: 328-332
PDF size: 241.22 Kb.


ABSTRACT

Objective. To estimate Covid-19 and pre-pandemic low respiratory infection (LRI) mortality in children and adolescents in Mexico. Materials and methods. We estimated the percentage of total mortality attributable to Covid-19 (95% confidence intervals; 95%CI) and made the corresponding estimates for pre-pandemic LRI mortality. Results. In 2019, LRIs represented 8.6% (95%CI 8.3, 8.9) of deaths in children aged 0-9 years, and 2.0% (95%CI 1.8, 2.3) in those aged 10-19 years. In 2020, the corresponding estimates for Covid-19 were 4.4% (95%CI 4.1, 4.6) and 3.7% (95%CI 3.4, 4.1). Conclusions. Relative to LRI, Covid-19 may be exerting a considerable mortality burden, particularly in older children and adolescents.


REFERENCES

  1. Bhopal SS, Bagaria J, Olabi B, Bhopal R. Children and young peopleremain at low risk of COVID-19 mortality. Lancet Child Adolesc Health. 2021;5(5):e12-e3. https//doi.org/10.1016/s2352-4642(21)00066-3

  2. Zar HJ, Dawa J, Fischer GB, Castro-Rodriguez JA. Challenges of COVID-19 in children in low- and middle-income countries. Paediatric respiratoryreviews. 2020;35:70-4. https://doi.org/10.1016/j.prrv.2020.06.016

  3. Stern D, Lajous M, De la Rosa B, Goldstein E. On the increasing incidenceof SARS-CoV- 2 in older adolescents and younger adults duringthe epidemic in Mexico. Salud Publica Mex. 2021;63(3):422-8. https://doi.org/10.21149/11817

  4. Palacio-Mejía LS, Wheatley-Fernández JL, Ordoñez-Hernández I, López-Ridaura R, Lopez Gatell-Ramirez H, Hernández Ávila M, et al. Estimacióndel exceso de mortalidad por todas las causas durante la pandemia delCovid-19 en México. Salud Publica Mex. 2021;63(2):211-24. https://doi.org/10.21149/12225

  5. Instituto Nacional de Estádistica y Geografía. Características de las defuncionesregsitradas en México durante 2020, preliminar. Aguascalientes:INEGI, 2021 [cited 26 Octuber 2021]. Available from: https://www.inegi.org.mx/contenidos/saladeprensa/boletines/2021/EstSociodemo/DefuncionesRegistradas2020_Pre_07.pdf

  6. Secretaría de Salud. Bases de datos del boletín estadístico sobre elexceso de mortalidad en México. Secretaría de Salud, 2021 [cited 26 Octuber2021]. Available from: https://datos.gob.mx/busca/dataset/bases-dedatos-del-boletin-estadistico-sobre-el-exceso-de-mortalidad-en-mexico

  7. Secretaría de Salud. COVID-19. Mexico City: Secretaría de Salud, 2021[cited 26 October 2021]. Available from: https://www.gob.mx/salud/documentos/datos-abiertos-152127

  8. Consejo Nacional de Población.Datos Abiertos de México - Proyeccionesde la Población de México y de las Entidades Federativas, 2016-2050.Conapo, 2021 [cited 26 Octuber 2021]. Available from: http://www.conapo.gob.mx/work/models/CONAPO/Datos_Abiertos/Proyecciones2018/pob_mit_proyecciones.csv

  9. Stern D, de la Garz-Arias E, García-Romero MT, Lajous M. Supplementalmaterial: COVID-19 mortality in children and adolescents in Mexico2021.Figshare. https://doi.org/10.6084/m9.figshare.16826449.v1

  10. Global Burden of Disease Collaborative Network. GBD Results Tool.2019 [cited 26 October 2021]. Available from: http://ghdx.healthdata.org/gbd-results-tool

  11. GBD 2016 Lower Respiratory Infections Collaborators. Estimatesof the global, regional, and national morbidity, mortality, and aetiologiesof lower respiratory tract infections in 195 countries: a systematicanalysis for the Global Burden of Disease Study 2015. Lancet Infect Dis.2017;17(11):1133-61. https://doi.org/10.1016/s1473-3099(17)30396-1

  12. González-García N, Castilla-Peón MF, Santos FS, Juárez RJ, BustamanteMEM, Hibert MAM, et al. Covid-19 incidence and mortalityby age strata and comorbidities in Mexico City: A Focus In The PediatricPopulation. medRxiv. 2021:2021.06.21.21259282. https://doi.org/10.1101/2021.06.21.21259282

  13. Bailey LC, Razzaghi H, Burrows EK, Bunnell HT, Camacho PEF, ChristakisDA, et al. Assessment of 135 794 pediatric patients tested for severe acuterespiratory syndrome coronavirus 2 across the United States. JAMA pediatrics.2021;175(2):176-84. https://doi.org/10.1001/jamapediatrics.2020.5052




2020     |     www.medigraphic.com